DCF Advisers’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-27,500
Closed -$1.67M – 82
2022
Q3
$1.67M Buy
+27,500
New +$869K 1.08% 30

Other funds holding PRTA

DCF Advisers's PRTA Position: Q3 2026 in Review

DCF Advisers increased its Prothena Corp (PRTA) stake by 77% in Q3 2026, buying an estimated $506K and bringing the position to 129,911 shares worth $1.09M. The position accounts for 0.25% of the portfolio, ranked #65.

DCF Advisers first reported a position in PRTA in Q1 2021 and has held it in 23 quarters since. The position peaked at $5.79M in Q2 2023. 60 funds tracked by Wall St. Rank hold PRTA as of Q3 2026.

  • DCF Advisers held 129,911 shares of Prothena Corp worth $1.09M as of Q3 2026.
  • DCF Advisers bought 56,664 Prothena Corp shares in Q3 2026, an estimated $506K.
  • Prothena Corp made up 0.25% of DCF Advisers's portfolio in Q3 2026, its #65 holding.
  • DCF Advisers first reported a position in Prothena Corp in Q1 2021 and has held it in 23 quarters since.
  • DCF Advisers's Prothena Corp position peaked at $5.79M in Q2 2023.
  • 60 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2026.

Based on DCF Advisers's 13F filing for Q3 2026, filed 4 Nov 2026.